What are the top disease areas for clinical drug trials?
Drug Discovery World
FEBRUARY 20, 2023
AstraZeneca’s Evusheld became the first antibody combination for pre-exposure prophylaxis (PrEP) against Covid-19 licensed in the UK. The approval was based on results from the PROpel Phase III trial, however, the drug was rejected by UK regulator NICE because it requires expensive genetic testing.
130 
Let's personalize your content